Status:
COMPLETED
Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
Lead Sponsor:
Tanta University
Conditions:
Myopic Traction Maculopathy
Pars Plana Vitrectomy
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
Investigate the effectiveness and safety of pars plans vitrectomy, with internal limiting membrane peeling for cases of myopic traction maculopathy
Detailed Description
Performing pars plana vitrectomy for highly myopic patients with decreased visual acuity is the standard of care for patients with myopic traction. A variety of findings are seen by Optical Coherence ...
Eligibility Criteria
Inclusion
- Highly myopic patients, having a refractive errors (spherical equivalent) of more than - 8 Diopter, or an axial length more than 26.5 mm.
- Best Corrected Visual Acuity less than 0.1
- Spectral Domain Optical Coherence Tomography showed; staphylomatous changes, with either: Macular retinoschisis, foveal retinal detachment, full thickness macular hole (with or without macualr hole retinal detachment), or lamellar macular hole, with epiretinal membrane
- At least 6 months follow-up
Exclusion
- Eyes with diffuse chorioretinal macular atrophy
- Concomitant presence of a choroidal neovascular membrane
- Young patients less than 21 years old.
- History of trauma
- Dense media opacity (corneal/ lenticular)
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04278079
Start Date
January 1 2015
End Date
February 1 2020
Last Update
February 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.